Eventide Asset Management’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.24M | Sell |
249,500
-133,196
| -35% | -$4.4M | 0.14% | 131 |
|
|
2025
Q1 | $15.4M | Buy |
382,696
+128,548
| +51% | +$5.17M | 0.31% | 98 |
|
|
2024
Q4 | $12M | Hold |
254,148
| – | – | 0.22% | 127 |
|
|
2024
Q3 | $13.4M | Hold |
254,148
| – | – | 0.23% | 106 |
|
|
2024
Q2 | $13.8M | Hold |
254,148
| – | – | 0.24% | 111 |
|
|
2024
Q1 | $17.8M | Sell |
254,148
-301,852
| -54% | -$21.2M | 0.28% | 99 |
|
|
2023
Q4 | $46.4M | Hold |
556,000
| – | – | 0.76% | 45 |
|
|
2023
Q3 | $16.4M | Hold |
556,000
| – | – | 0.29% | 95 |
|
|
2023
Q2 | $18.1M | Hold |
556,000
| – | – | 0.31% | 89 |
|
|
2023
Q1 | $19.6M | Hold |
556,000
| – | – | 0.36% | 86 |
|
|
2022
Q4 | $25.5M | Buy |
+556,000
| New | +$25.5M | 0.5% | 64 |
|